Biliary atresia is a rare disease of infancy, which has changed within 30 years from being
fatal to being a disorder for which effective palliative surgery or curative liver transplantation …

Biliary atresia is a mystifying cause of neonatal cholestasis, manifested by progressive
inflammation and fibrosis of both the extrahepatic and intrahepatic bile ducts. It is a …

Importance Biliary atresia is the most common cause of end-stage liver disease in children.
Controversy exists as to whether use of steroids after hepatoportoenterostomy improves …

Extra-hepatic biliary atresia occurs in approximately 1: 15 000 live births leading to about 50
new cases/year in the UK. Presentation is with prolonged jaundice, usually in a term baby …

Biliary atresia is a rare neonatal disease of unknown etiology, where obstruction of the
biliary tree causes severe cholestasis, leading to biliary cirrhosis and death in the first years …

The objective of this study was to evaluate adjuvant corticosteroids after Kasai
portoenterostomy for biliary atresia. The study consisted of a prospective, 2‐center, double …

Background & Aims The effect of adjuvant steroids in infants with biliary atresia (BA) is not
clear and evidence of benefit is lacking. Methods During the period Jan. 2000–Dec. 2011 …

The use of adjuvant steroids following Kasai porteoenterostomy (KPE) for biliary atresia is
controversial. The aim of this study was twofold: a systematic review of published literature …

Biliary atresia (BA) is a condition unique to infancy. It results from inflammatory destruction of
the intrahepatic and extrahepatic bile ducts. It is the most frequent surgically correctable liver …

Abstract Background/Objectives Adjuvant steroid therapy has become popular in the
postoperative management of biliary atresia. However, the benefits of steroid therapy are …